DRL takes a hit of 9% on US court order

Dr Reddy’s Laboratories reeled early Monday, plunging 9% after the New Jersey District Court granted a preliminary injunction against the sale of the generic version of Suboxone used for treating opioid dependence.
The stock crashed 9.48% to hit a low of Rs 2,097.70 on the BSE.

For Real Time News & Trading Trends Keep Liking Epic Research Limited

Facebook

Twitter

YouTube

Pinterest

Linkedin

Google+

Share Button

About the Author

Epic Research
Epic Research
Epic Research - Investment Adviser is a leading financial services provider with presence in Indian and other global capital markets. Call on - 0731-664-2300